Nicholas A. Smith

Array ( [id] => 6234812 [patent_doc_number] => 20100266530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'FcRN ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/919596 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15739 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266530.pdf [firstpage_image] =>[orig_patent_app_number] => 11919596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5852017 [patent_doc_number] => 20060235208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Fc variants with optimized properties' [patent_app_type] => utility [patent_app_number] => 11/396495 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 27345 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235208.pdf [firstpage_image] =>[orig_patent_app_number] => 11396495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183417 [patent_doc_number] => 20110123440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Altered Antibody FC Regions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/887481 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 17944 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123440.pdf [firstpage_image] =>[orig_patent_app_number] => 11887481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441393 [patent_doc_number] => 20100104564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Altered Antibody Fc Regions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/887467 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 16704 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104564.pdf [firstpage_image] =>[orig_patent_app_number] => 11887467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693691 [patent_doc_number] => 20060153838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Fc region variants' [patent_app_type] => utility [patent_app_number] => 11/384134 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 49090 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153838.pdf [firstpage_image] =>[orig_patent_app_number] => 11384134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 511457 [patent_doc_number] => 07196177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same' [patent_app_type] => utility [patent_app_number] => 11/376338 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3825 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196177.pdf [firstpage_image] =>[orig_patent_app_number] => 11376338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619441 [patent_doc_number] => 20060188974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Human protein kinases and protein kinase-like enzymes' [patent_app_type] => utility [patent_app_number] => 11/375615 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75706 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188974.pdf [firstpage_image] =>[orig_patent_app_number] => 11375615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596226 [patent_doc_number] => 20060160143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Mitogenic oxygenases' [patent_app_type] => utility [patent_app_number] => 11/377884 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20242 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160143.pdf [firstpage_image] =>[orig_patent_app_number] => 11377884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677390 [patent_doc_number] => 20060182745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Anti-CD63 antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/332890 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12353 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182745.pdf [firstpage_image] =>[orig_patent_app_number] => 11332890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5187998 [patent_doc_number] => 20070166306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Anti-CD19 antibody composition and method' [patent_app_type] => utility [patent_app_number] => 11/334003 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6021 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166306.pdf [firstpage_image] =>[orig_patent_app_number] => 11334003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681718 [patent_doc_number] => 20080247944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Irta-2 Antibodies and Their Uses' [patent_app_type] => utility [patent_app_number] => 11/794606 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27772 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247944.pdf [firstpage_image] =>[orig_patent_app_number] => 11794606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887580 [patent_doc_number] => 20060275282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Antibodies and Fc fusion proteins with altered immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/332619 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 132 [patent_figures_cnt] => 132 [patent_no_of_words] => 36887 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275282.pdf [firstpage_image] =>[orig_patent_app_number] => 11332619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753984 [patent_doc_number] => 20060223133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Monoclonal antibody against connective tissue growth factor and medicinal uses thereof' [patent_app_type] => utility [patent_app_number] => 11/324769 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 37364 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223133.pdf [firstpage_image] =>[orig_patent_app_number] => 11324769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732282 [patent_doc_number] => 20060257399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform' [patent_app_type] => utility [patent_app_number] => 11/317191 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22941 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257399.pdf [firstpage_image] =>[orig_patent_app_number] => 11317191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672085 [patent_doc_number] => 20060177439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'FcgammaRIIB-specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/305787 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 61612 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177439.pdf [firstpage_image] =>[orig_patent_app_number] => 11305787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5636953 [patent_doc_number] => 20060067926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Novel serine threonine kinase member, h2520-59' [patent_app_type] => utility [patent_app_number] => 11/294997 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 38574 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20060067926.pdf [firstpage_image] =>[orig_patent_app_number] => 11294997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051377 [patent_doc_number] => 20070031922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Altered polypeptides with increased half-life' [patent_app_type] => utility [patent_app_number] => 11/281880 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28923 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031922.pdf [firstpage_image] =>[orig_patent_app_number] => 11281880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169378 [patent_doc_number] => 09200079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 11/274065 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 41 [patent_no_of_words] => 28314 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11274065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648373 [patent_doc_number] => 20060134105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'IgG immunoglobulin variants with optimized effector function' [patent_app_type] => utility [patent_app_number] => 11/256060 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 67807 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134105.pdf [firstpage_image] =>[orig_patent_app_number] => 11256060 [rel_patent_id] =>[rel_patent_doc_number] =>)